Keyhole-limpet haemacyanin and immune ribonucleic acid immunotherapy of murine transitional cell carcinoma
- PMID: 7303346
- DOI: 10.1007/BF00256891
Keyhole-limpet haemacyanin and immune ribonucleic acid immunotherapy of murine transitional cell carcinoma
Abstract
Transitional cell carcinoma is known to be an immunogenic tumour. This immunogenicity has been the basis of a search for effective immunotherapeutic agents and for the evaluation in this study of two additional agents, keyhole-limpet haemacyanin (KLH) and immune ribonucleic acid (RNA) extract. The results in this animal model showed KLH to be a potent non-specific stimulant of the immune response which caused both a reduction in tumour growth and a prolongation of animal survival (p = 0.01). No anti-tumour effects were observed with either local or systemic RNA.
Similar articles
-
Keyhole limpet hemocyanin immunotherapy of murine bladder cancer.Urol Res. 1993 Jan;21(1):33-7. doi: 10.1007/BF00295189. Urol Res. 1993. PMID: 8456536
-
Keyhole-limpet haemocyanin (KLH) immunotherapy of murine transitional cell carcinoma.Urol Res. 1983;11(6):263-5. doi: 10.1007/BF00256343. Urol Res. 1983. PMID: 6659223
-
Immunotherapy of murine bladder cancer with keyhole limpet hemocyanin (KLH).J Urol. 1993 Mar;149(3):648-52. doi: 10.1016/s0022-5347(17)36172-4. J Urol. 1993. PMID: 8437283 Review.
-
Immunotherapy of murine transitional cell carcinoma.J Urol. 1982 Nov;128(5):1104-8. doi: 10.1016/s0022-5347(17)53354-6. J Urol. 1982. PMID: 6757465
-
Keyhole limpet haemocyanin in experimental bladder cancer: literature review and own results.Eur Urol. 2000;37 Suppl 3:34-40. doi: 10.1159/000052390. Eur Urol. 2000. PMID: 10828685 Review.
Cited by
-
Keyhole limpet hemocyanin immunotherapy of murine bladder cancer.Urol Res. 1993 Jan;21(1):33-7. doi: 10.1007/BF00295189. Urol Res. 1993. PMID: 8456536
-
BCG in the treatment of superficial cancer of the bladder: a review.Med Oncol Tumor Pharmacother. 1993;10(1-2):31-6. doi: 10.1007/BF02987766. Med Oncol Tumor Pharmacother. 1993. PMID: 8258992 Review.
-
Keyhole-limpet haemocyanin (KLH) immunotherapy of murine transitional cell carcinoma.Urol Res. 1983;11(6):263-5. doi: 10.1007/BF00256343. Urol Res. 1983. PMID: 6659223
-
Biologic response modifiers in the management of superficial bladder cancer.World J Urol. 1997;15(2):96-102. doi: 10.1007/BF02201979. World J Urol. 1997. PMID: 9144898 Review.
References
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical